Permanent Hair Loss Due to the Chemotherapy Drug Taxotere
Cancer is responsible for taking the lives of many innocent individuals each and every year. Because of the invasive and life-threatening treatments these helpless individuals have to endure, only some are able to carry on with their lives after undergoing chemotherapy and being prescribed medications that are known to not only help the body, but also destroy it. We know that chemotherapy and the required medications can be risky, but when a woman manages to pull through and expects to live a normal life, she is not always able to do so. The permanent side effects caused by Taxotere are a constant reminder of the battle she fought.
As of recently, many women are learning that Taxotere, which was developed by Sanofi-Aventis and is used during the chemotherapy process, is helping them survive, but is also leaving them having to face what many would consider a mortifying flaw. This being the side effect of permanent hair loss after taking the drug Taxotere has left many women feeling defeminized, devastated, and distressed.
Although the creators and developers of Taxotere have provided cancer patients with a medication that has helped a substantial number of individuals overcome the disease, rather than informing patients of the facts surrounding the side effects of taking this drug, they simply supply a warning stating that it could cause “temporary” hair loss, which is not only incorrect but deceitful as well.
Cancer is a disease that can develop in anyone and at any given time, and while it is out of our control as to who becomes a victim, you are provided with the choice of how you want to treat it. And because the manufacturers of Taxotere have taken away your right to make an informed decision based on the harmful effects associated with using Taxotere, it is time they are held accountable for causing you to have to live with a condition you may have been able to avoid had you been made aware that alopecia, also known as permanent hair loss, could occur through treatment with Taxotere.
Unfortunately, the manufacturer of Taxotere has triumphed in both bellwether trials and appears to be primed to avoid responsibility for victims of hair loss due to taking the drug. There appears to be hope for those Taxotere users who have been diagnosed with vision impairment, however, at this time Morris Bart is no longer able to accept these cases.